Park Avenue Securities LLC Invests $260,000 in Chemed Co. (NYSE:CHE)

Park Avenue Securities LLC acquired a new stake in shares of Chemed Co. (NYSE:CHE) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 433 shares of the company’s stock, valued at approximately $260,000.

Other hedge funds also recently made changes to their positions in the company. American National Bank & Trust bought a new position in Chemed in the third quarter valued at $61,000. Centaurus Financial Inc. increased its position in shares of Chemed by 334.6% during the 2nd quarter. Centaurus Financial Inc. now owns 2,147 shares of the company’s stock valued at $1,165,000 after purchasing an additional 1,653 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in shares of Chemed during the 2nd quarter valued at about $1,955,000. Quarry LP lifted its position in Chemed by 721.7% in the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after buying an additional 166 shares during the last quarter. Finally, Second Line Capital LLC boosted its stake in Chemed by 7.6% in the second quarter. Second Line Capital LLC now owns 3,925 shares of the company’s stock worth $2,130,000 after buying an additional 277 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Chemed Stock Performance

CHE stock opened at $589.88 on Monday. The company has a market capitalization of $8.93 billion, a PE ratio of 31.75, a price-to-earnings-growth ratio of 2.44 and a beta of 0.44. Chemed Co. has a one year low of $497.36 and a one year high of $654.62. The company’s 50 day moving average price is $580.69 and its two-hundred day moving average price is $571.53.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. During the same period in the prior year, the firm earned $4.71 earnings per share. The business’s revenue for the quarter was up 7.6% on a year-over-year basis. On average, research analysts predict that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were paid a $0.50 dividend. This is a boost from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s payout ratio is 10.76%.

Insider Buying and Selling at Chemed

In related news, Director George J. Walsh III sold 200 shares of Chemed stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total value of $115,590.00. Following the transaction, the director now directly owns 3,446 shares of the company’s stock, valued at $1,991,615.70. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $569.63, for a total value of $1,139,260.00. Following the completion of the sale, the chief executive officer now owns 105,735 shares in the company, valued at approximately $60,229,828.05. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director George J. Walsh III sold 200 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total value of $115,590.00. Following the transaction, the director now directly owns 3,446 shares in the company, valued at $1,991,615.70. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 9,144 shares of company stock worth $5,264,839. 3.32% of the stock is currently owned by insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.